CD3 Archives - Medical Conferences

EPCORE CLL-1: Promising data for epcoritamab in high-risk Richter’s transformation

Presented By

Prof. Arnon Kater, University of Amsterdam, the Netherlands

Trial

Phase 1/2, EPCORE CLL-1

Conference

EHA 2024

Type

Peer-reviewed article

12 August 2024 14:27

Clinically meaningful outcomes for mosunetuzumab across follicular lymphoma subgroups

Presented By

Dr Sarit Assouline, Jewish General Hospital, Canada

Trial

Phase 1/2

Conference

EHA 2024

Type

Peer-reviewed article

12 August 2024 14:26

Primary phase 2 efficacy and safety results of M-Pola in relapsed/refractory LBCL

Presented By

Dr Elizabeth Budde, City of Hope National Medical Center, CA, USA

Trial

Phase 1/2

Conference

ASH 2023

Type

Peer-reviewed article

7 February 2024 14:59

Early ctDNA reduction in metastatic uveal melanoma correlates better with OS than RECIST response

Presented By

Dr Alexander Shoushtari, Memorial Sloan Kettering Cancer Center, NY, USA

Trial

Phase 1/2, IMCgp100-202

Conference

ESMO 2021

Type

Peer-reviewed article

19 November 2021 09:09

Immune therapy of multiple myeloma

Presented By

Prof. Noopur Raje, Massachusetts General Cancer Center, USA

Trial

KarMMA; CARTITUDE-1; UNIVERSAL

Conference

EHA 2021

Type

Peer-reviewed article

5 August 2021 14:49

Promising first-in-human trial of epcoritamab in B-NHL

Presented By

Dr Martin Hutchings, Copenhagen University Hospital, Denmark

Trial

Phase 1/2, GEN3013

Conference

EHA 2020

Type

Peer-reviewed article

9 September 2020 12:30